Manipal Health lists at 11% premium, beats GMP estimates; should you buy? - business-standard.com

GeneralWednesday, 5 August 20261 views0 comments

Manipal Health lists at 11% premium, beats GMP estimates; should you buy? - business-standard.com

By ETF Desk

Share:Facebook X / Twitter WhatsApp

Share:Facebook X / Twitter WhatsApp

Comments (0)

Sign in to join the conversation

No comments yet. Be the first to comment!